Balchem Corporation is a high-quality specialty chemicals business — a perfect Piotroski score of 9 out of 9, a moat score of 7.0, and best-in-class margins — with a consistent earnings delivery record, but the stock screens expensive at a forward multiple of 26.8 times and offers only 4.3% headroom to the take-profit target, leaving the risk/reward insufficient to justify a new position at current levels.
Thesis pillars
- Expensive Valuation Screens→Stable
- High Quality Piotroski Perfect Score→Stable
- Consistent Earnings Delivery→Stable
- +1 more pillar — see the Why tab for full reasoning
Balchem Corporation (BCPC) Stock Analysis
Breakout setup · Catalyst-Driven edge
Basic Materials · Specialty Chemicals
Sell if holding. Analyst target reached at $166.46 — A.R:R 0.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation.
We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that... Read more
Sell if holding. Analyst target reached at $166.46 — A.R:R 0.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation. Chart setup: Golden cross, above all MAs, RSI 57, MACD bullish. Score 5.3/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 24d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-07-07Recent Developments — Balchem Corporation
Latest news
- NEWS Balchem beat its 2030 emissions goal in 2025, cutting 31% from 2020 - Stock Titan — Stock Titan positive
- NEWS Is Balchem (BCPC) stock trading at a premium | Q4 2025: Earnings Fall Short - PEG Ratio - UBND thành phố Hải Phòng — UBND thành phố Hải Phòng negative
- NEWS Balchem Corp (BCPC) Stock Price, Trades & News - GuruFocus — GuruFocus neutral
- NEWS Balchem (BCPC) Stock: Breaking Downtrend? (In Focus) 2026-04-20 - Viral Trade Signals - Cổng thông tin điện tử Tỉnh Sơn — Cổng thông tin điện tử Tỉnh Sơn La neutral
- NEWS Balchem (BCPC) Stock: Breaking Downtrend? (In Focus) 2026-04-20 - Viral Trade Signals - Xã Vĩnh Công — Xã Vĩnh Công neutral
Generated 2026-07-07T12:51:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $166.46 — A.R:R 0.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation. Chart setup: Golden cross, above all MAs, RSI 57, MACD bullish. Prior stop was $159.87. Score 5.3/10, moderate confidence.
Take-profit target: $170.64 (+2.2% upside). Prior stop was $159.87. Stop-loss: $159.87.
Analyst target reached - limited upside remaining; Expensive valuation.
Balchem Corporation trades at a P/E of 34.7 (forward 27.6). TrendMatrix value score: 3.9/10. Verdict: Sell.
9 analysts cover BCPC with a consensus score of 4.0/5. Average price target: $201.
What does Balchem Corporation do?We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional,...
We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that offer products and services to different markets: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.